Some features of beckman.com will be unavailable from 8:00 p.m. PDT Saturday, December 7 until 12:00 a.m. PDT, Sunday, December 8 for planned maintenance. During this time, you will not be able to log in to use account features such as online shopping, shopping lists and order tracking.
Please ensure your orders are processed prior to this maintenance period or contact Client Services for additional assistance.
How can immunotherapy help with inflammatory bowel disease (IBD)?
Inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn’s disease, involve chronic inflammation of the digestive tract. Patients suffering from IBD have an elevated risk of developing colon cancer, blood clots, and other manifestations of chronic inflammation. Current therapies are geared together managing the symptoms of IBD, but novel immunotherapies are utilizing naturally found bacteriophages with strong immunosuppressive properties with the aim of reducing intestinal epithelial cell inflammation. These therapies have been found to be safe when used in combination with anti-inflammatory medication.1
1. A. Gorski, et al., "Bacteriophages targeting intestinal epithelial cells: a potential novel form of immunotherapy," Cell Mol Life Sci 75(4) 589-595, 2018.
Oops. The page you wanted could not be found, so we brought you to something similar. If you still can't find what you want, try searching our site instead.